Virginia US Rep. Gerry Connolly announces cancer diagnosis

Longstanding US Rep. Gerry Connolly of Virginia says he is battling esophageal cancer
RICHMOND, Va. — U.S. Rep. Gerry Connolly, a Democrat representing Virginia's most populous county in Congress, said Thursday that he is battling esophageal cancer.
Gerry Connolly, longtime Virginia congressman, says he has esophageal cancer
Connolly, who represents a swath of Northern Virginia, easily won reelection to a ninth term in the House this week.
Virginia Rep. Gerry Connolly announces cancer diagnosis 2 days after winning re-election
U.S. Rep. Gerald "Gerry" Connolly has announced that he has cancer of the esophagus two days after winning re-election for his ninth term in Congress.
Democratic Rep. Gerry Connolly announces cancer diagnosis
Democratic Rep. Gerry Connolly has esophagus cancer, the longtime Virginia congressman announced in a statement Thursday.
Virginia US Rep. Gerry Connolly announces cancer diagnosis after reelection
U.S. House Representative Gerald “Gerry” Connolly announced Thursday that he was diagnosed with esophagus cancer. His announcement comes just days after he was reelected to Virginia’s 11th District. In a statement shared on X,
Gerry Connolly discloses cancer of esophagus diagnosis
Rep. Gerry Connolly (D-Va.) revealed Thursday that he has been diagnosed with cancer of the esophagus, saying he is “very confident in a successful outcome.” “A few days ago, I learned I joined the ranks of millions of Americans.
Rep. Gerry Connolly reveals cancer treatment after reelection
Rep. Gerry Connolly, D-11th, a Northern Virginia political powerhouse for decades, announced Thursday that he has been diagnosed with esophageal cancer and would begin treatment immediately.
Research explores non-invasive diagnosis for Barrett's esophagus
New research is exploring low-cost, non-invasive ways to diagnose Barrett's esophagus, a condition associated with deadly ...
Verywell Health on MSN1mon
The Anatomy of the Esophagus
A number of conditions can impact the esophagus, ranging from the relatively mild to the much more serious. Disorders and ...
Medscape11mon
Barrett's Esophagus: Clinical Implications
Esophageal resection should include all of ... with endoscopic ultrasound and high-frequency probes. The major problems associated with ablative techniques include difficulty in differentiating ...
Future Market Insights6h
Global Esophageal Catheters Market Set for Strong Growth, Expected to Reach USD 4.5 Billion by 2032
Esophageal Catheters Market. The global esophageal catheters market is poised for significant expansion, with a projected market value of USD 2.2 billion in 2022, and a robust com ...
Health.com1mon
What Makes It Hurt To Swallow?
These include certain infections or health conditions of the mouth, throat, or esophagus, as well as other oral and eating problems. Throat infections such as viral pharyngitis (sore throat ...
News Medical3mon
Esophageal Cancer News and Research
The transition from the esophagus to the stomach is a delicate region from a medical point of view, often associated with pathological disorders leading to cancer. Monitoring levels of DNA shed by ...
Daily Courier6d
WVU Cancer Institute’s Thakkar first in the world to use device that lowers risk of esophageal cancer
A WVU Cancer Institute team led by Shyam Thakkar, M.D., is the first in the world to commercially use the new, FDA-approved 180° C2 Cryoballoon in the treatment of Barrett’s ...
Previse Showcases New Data Highlighting Clinical Utility of Esopredict® Barrett's Esophagus Prognostic Test at ACG 2024
Previse, a gastrointestinal health company, today announced the company presented prospective real-world clinical utility ...
PharmiWeb11d
Global Esophageal Implant Market Poised for Strong Growth, Expected to Surpass USD 280 Million by 2033 at a 6.7% of CAGR
Esophageal Implant MarketThe global esophageal implant market is set for substantial growth, with its valuation projected to reach USD 147 million in 2023. Over the next decade, the market is ...
Business Wire1mon
New Data at AFS 2024 Demonstrates the Strength of Castle Biosciences’ TissueCypher® Test in Independently Predicting Risk of Developing Esophageal Cancer, Guiding Risk ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present new data supporting the ...